KDM5C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.916760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.804000E-01
Normal-vs-Stage2
1.734640E-01
Normal-vs-Stage3
2.361400E-01
Normal-vs-Stage4
7.608000E-01
Stage1-vs-Stage2
2.255200E-01
Stage1-vs-Stage3
2.258800E-01
Stage1-vs-Stage4
9.330200E-01
Stage2-vs-Stage3
3.076600E-01
Stage2-vs-Stage4
3.943600E-01
Stage3-vs-Stage4
3.087000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.553760E-01
Normal-vs-AfricanAmerican
9.111800E-01
Normal-vs-Asian
4.626400E-01
Caucasian-vs-AfricanAmerican
9.302500E-02
Caucasian-vs-Asian
5.033200E-01
AfricanAmerican-vs-Asian
4.540400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.180000E-01
Normal-vs-Female
7.315600E-01
Male-vs-Female
1.48979717451425E-11
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.983800E-01
Normal-vs-Age(41-60Yrs)
5.289200E-01
Normal-vs-Age(61-80Yrs)
9.014500E-02
Normal-vs-Age(81-100Yrs)
1.703450E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.442800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.720570E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.738800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.152500E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.319700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.481400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.455600E-02
Normal-vs-Daily Drinker
2.850000E-01
Normal-vs-Weekly Drinker
3.184600E-01
Normal-vs-Occasional Drinker
3.612200E-01
Normal-vs-Social Drinker
6.277200E-01
Non Drinker-vs-Daily Drinker
3.645200E-01
Non Drinker-vs-Weekly Drinker
2.958200E-01
Non Drinker-vs-Occasional Drinker
1.109420E-01
Non Drinker-vs-Social Drinker
4.371700E-02
Daily Drinker-vs-Weekly Drinker
8.760600E-01
Daily Drinker-vs-Occasional Drinker
5.953800E-01
Daily Drinker-vs-Social Drinker
3.192600E-01
Weekly Drinker-vs-Occasional Drinker
7.340200E-01
Weekly Drinker-vs-Social Drinker
4.319000E-01
Occasional Drinker-vs-Social Drinker
5.780800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.814600E-01
Normal-vs-Grade 2
9.807000E-01
Normal-vs-Grade 3
9.831600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.907000E-01
Grade 1-vs-Grade 3
9.778200E-01
Grade 1-vs-Grade 4
9.814600E-01
Grade 2-vs-Grade 3
9.527200E-01
Grade 2-vs-Grade 4
9.807000E-01
Grade 3-vs-Grade 4
9.831600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.587900E-02
Normal-vs-NonDiabetic
2.636200E-01
Diabetic-vs-NonDiabetic
2.818300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.139400E-01
Normal-vs-NoPancreatitis
1.353240E-01
Pancreatitis-vs-NoPancreatitis
1.290410E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.822800E-01
Normal-vs-N1
1.527030E-01
N0-vs-N1
7.516400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.092800E-01
Normal-vs-TP53-NonMutant
3.271600E-01
TP53-Mutant-vs-TP53-NonMutant
5.475000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
